Td Asset Management Inc Karyopharm Therapeutics Inc. Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$9.85 - $17.69 $286,506 - $514,549
-29,087 Closed
0 $0
Q3 2020

Nov 10, 2020
SELL
$14.14 - $19.71 $349,258 - $486,837
-24,700 Reduced 45.92%
29,087 $425,000
Q2 2020

Aug 13, 2020
BUY
$16.6 - $25.25 $378,397 - $575,573
22,795 Added 73.55%
53,787 $1.02 Million
Q1 2020

May 15, 2020
BUY
$14.38 - $27.72 $445,664 - $859,098
30,992 New
30,992 $595,000

Others Institutions Holding KPTI

# of Institutions
94
Shares Held
56.5M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $49.5M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email